Effects of dicloxacillin: A Synthesis of Findings from 24 Studies
- Home
- Effects of dicloxacillin
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of dicloxacillin: A Synthesis of Findings from 24 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major research findings
Dicloxacillin has been shown to be effective against various strains of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). 24 . Dicloxacillin inhibits the first step in wall teichoic acid biosynthesis (TarO), which weakens the cell wall of MRSA and makes it more susceptible to β-lactam antibiotics. 24 .
In a mouse peritonitis model, dicloxacillin demonstrated intracellular activity against Staphylococcus aureus. 14 . Dicloxacillin was found to accumulate inside cells more effectively than other antibiotics and significantly reduced the number of intracellular bacteria. 14 .
Dicloxacillin exhibited similar bactericidal activity compared to vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) clinical isolates, as evaluated by population analyses, time-kill assays, and a murine thigh infection model. 2 . These findings suggest that antistaphylococcal penicillins, like dicloxacillin, may be effective against OS-MRSA infections. 2 .
Dicloxacillin demonstrated synergistic effects with the phenothiazine drug thioridazine against MRSA, vancomycin intermediate-susceptible S. aureus (VISA), and methicillin-resistant Staphylococcus epidermidis (MRSE). 20 . This synergy suggests that cell wall thickening does not interfere with the effects of thioridazine. 20 .
Benefits and risks
Benefit Summary
Dicloxacillin could be a viable treatment option for various Staphylococcus aureus infections, including MRSA. 24 , 2 . Dicloxacillin accumulates efficiently within cells and can effectively reduce the number of intracellular bacteria. 14 . Synergistic effects have been observed when combining dicloxacillin with thioridazine against MRSA, VISA, and MRSE, suggesting potential for enhanced treatment approaches. 20 .
Risk Summary
Similar to other antibiotics, dicloxacillin poses potential side effects. 13 . Common side effects include gastrointestinal disturbances (diarrhea, nausea, vomiting), rash, and liver dysfunction. 13 . Dicloxacillin may interact with anticoagulants like warfarin. .
Comparison of studies
Commonalities in studies
Numerous studies have highlighted the effectiveness of dicloxacillin as a treatment option for Staphylococcus aureus infections. 24 , 14 , 2 , 20 . A common theme is the potential for enhanced efficacy when dicloxacillin is combined with other antibiotics. 24 , 20 .
Differences in studies
The effectiveness of dicloxacillin can vary depending on the specific strain of Staphylococcus aureus and the combination of drugs used. 24 , 2 , 20 . Individual patient factors, such as age, gender, and kidney function, can also influence the effectiveness of dicloxacillin. 18 , 4 .
Consistency and contradictions in the results
While various studies consistently demonstrate the effectiveness of dicloxacillin against Staphylococcus aureus infections, 24 , 14 , 2 , 20 , there is a suggestion of variability in its effectiveness based on the specific strain of Staphylococcus aureus and the combination of drugs used. 24 , 2 , 20 . Tailoring treatment strategies to individual patients is crucial to maximize the therapeutic benefits of dicloxacillin. 18 , 4 .
Considerations for applying the results to real life
It is crucial to take dicloxacillin as prescribed by a healthcare professional. 13 . Self-adjusting dosages or discontinuing the medication without medical advice may worsen infections. 13 . Dicloxacillin can interact with other medications like anticoagulants (warfarin), so it is essential to inform your doctor about any other drugs you are taking. .
Limitations of current research
Current research on the effects of dicloxacillin is still limited. 24 , 14 , 2 , 20 . Further investigation is required to fully understand the impact of dicloxacillin across various Staphylococcus aureus strains, its interactions with other medications, and its long-term effects and safety. 24 , 2 , 20 , 18 , 4 .
Future research directions
To gain a more comprehensive understanding of dicloxacillin's effects, further research is needed to explore its efficacy across a wider range of Staphylococcus aureus strains, its interactions with other medications, and its long-term effects and safety. 24 , 2 , 20 , 18 , 4 .
Conclusion
Dicloxacillin shows potential as an effective treatment for Staphylococcus aureus infections. 24 , 14 , 2 , 20 . However, it is crucial to acknowledge the potential for variability in its effectiveness based on the specific strain of Staphylococcus aureus and the combination of drugs used. 24 , 2 , 20 . To maximize therapeutic benefits, personalized treatment approaches tailored to individual patients are essential. 18 , 4 .
Benefit Keywords
Risk Keywords
Article Type
Author: KrogsgaardM R, HansenB A, SlotsbjergT, JensenP
Language : English
Author: LabrouMaria, MichailGeorge, NtokouEleni, PittarasTheodore E, PournarasSpyros, TsakrisAthanassios
Language : English
Author: Sánchez-SánchezMario, Cruz-PulidoWendy Lizeth, Bladinieres-CámaraEduardo, Alcalá-DuránRodrigo, Rivera-SánchezGildardo, Bocanegra-GarcíaVirgilio
Language : English
Language : English
Author: BjörnssonHjalti Már, EinarsdóttirAsa Elísa, ClausenMichael V
Language : Icelandic
Author: Villegas-GuzmanPaola, Silva-AgredoJavier, Giraldo-AguirreAna L, Flórez-AcostaOscar, PetrierChristian, Torres-PalmaRicardo A
Language : English
Author: IkonomidisAlexandros, MichailGeorge, VasdekiAfroditi, LabrouMaria, KaravasilisVasilis, StathopoulosConstantinos, ManiatisAntonios N, PournarasSpyros
Language : English
Author: SinthuchaiDonwichai, BoontanonSuwanna Kitpati, BoontanonNarin, PolprasertChongrak
Language : English
Author: CercaNuno, MartinsSilvia, SillankorvaSanna, JeffersonKimberly K, PierGerald B, OliveiraRosario, AzeredoJoana
Language : English
Author: CámaraM, Gallego-PicóA, GarcinuñoR M, Fernández-HernandoP, Durand-AlegríaJ S, SánchezP J
Language : English
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Author: HertzFrederik Boetius, Løbner-OlesenAnders, Frimodt-MøllerNiels
Language : English
Author: FeldmannM, Tenhagen genannt EmmingS, HoedemakerM
Language : German
Author: Zand IraniAnis, AlmuwaisAhmed, GibbonsHolly
Language : English
Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.
Author: SandbergAnne, HesslerJonas H R, SkovRobert L, BlomJens, Frimodt-MøllerNiels
Language : English
Author: PinhoA, CoutinhoI, GameiroA, GouveiaM, GonçaloM
Language : English
Author: BarbosaSilvia, AnteloLuis T, TaboadaPablo, MosqueraVíctor
Language : English
Author: Barboza-CoronaJosé Eleazar, de la Fuente-SalcidoNorma, Alva-MurilloNayeli, Ochoa-ZarzosaAlejandra, López-MezaJoel E
Language : English
Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics.
Author: PutnamWendy S, WooJonathan M, HuangYong, BenetLeslie Z
Language : English
Author: Fabregat-SafontDavid, PitarchElena, BijlsmaLubertus, MateiIonut, HernándezFélix
Language : English
Combination of thioridazine and dicloxacillin as a possible treatment strategy of staphylococci.
Author: RasmussenKristian Severin, PoulsenMarianne Ø, JacobsenKirstine, SkovMarianne N, KolmosHans Jørn, KallipolitisBirgitte H, KlitgaardJanne K
Language : English
Author: RasmussenJon Bjarke, KnudsenJenny Dahl, ArpiMagnus, SchønheyderHenrik Carl, BenfieldThomas, OstergaardChristian
Language : English
Author: SamanidouVictoria F, NisyriouStyliani A, PapadoyannisIoannis N
Language : English
Author: Campista-LeónSamuel, Garcia-GuerreroJoel Tohevaris, Olimón-AndalónVicente, Peinado-GuevaraLuz Isela
Language : English
Author: LeeSang Ho, WangHao, LabroliMarc, KoseogluSandra, ZuckPaul, MayhoodTodd, GillCharles, MannPaul, SherXinwei, HaSookhee, YangShu-Wei, MandalMihir, YangChristine, LiangLianzhu, TanZheng, TawaPaul, HouYan, KuvelkarReshma, DeVitoKristine, WenXiujuan, XiaoJing, BatchlettMichelle, BalibarCarl J, LiuJenny, XiaoJianying, MurgoloNicholas, GarlisiCharles G, ShethPayal R, FlatteryAmy, SuJing, TanChristopher, RoemerTerry
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.